Assay Design’s senior management will remain actively involved with Enzo Life Sciences. With this latest acquisition, Enzo Life Sciences now has US operations in New York, Pennsylvania, Michigan and California, and overseas facilities in Switzerland, the UK and Belgium, as well as more than 50 distributors worldwide.
Daniel Calvo, president and CEO of Assay Designs, said: “Joining with Enzo Life Sciences is a natural progression for the company. Their complementary product lines and global infrastructure will enable Assay Designs to achieve accelerated growth and a stronger market position than can be accomplished as a standalone company.
“We look forward to participating in Enzo’s on-going expansion as a leader in the life sciences and improving our position within the international scientific community.”